Emergent BioSolutions
Climate Impact & Sustainability Data (2020, 2021, 2022, 2023)
Reporting Period: 2020
Environmental Metrics
ESG Focus Areas
- Access to medicine
- Community engagement
- Compliance
- Corporate governance
- Diversity, equity, and inclusion
- Employee engagement
Environmental Achievements
- Winnipeg site awarded a certificate of environmental impact achievement for three years in a row for their garment recycling program that diverted up to 16,000 pounds of waste annually from the landfill.
Social Achievements
- Launched a platform to support a portfolio of recognition opportunities, including peer-to-peer kudos, monetary awards, as well as an annual award nomination process.
- Introduced a one-time Special Ownership Award to recognize employee contributions, with every full-time employee below the senior vice president level receiving a one-time, fully-vested $7,500 stock award.
- Launched three inaugural Emergent Resource Groups (ERGs) for Black, women, and military veteran employees.
- Enterprise-wide turnover rate better than the benchmark for the life sciences industry in 2020.
- Donated 5,214 units (10,428 doses) of NARCAN® Nasal Spray to high schools, colleges, universities, public libraries, YMCAs, and nonprofits.
Governance Achievements
- Established a special committee on manufacturing and quality oversight, composed of independent directors.
- Implemented a three-year Quality Enhancement Plan (QEP) to maximize quality performance and minimize quality risk.
Climate Goals & Targets
Environmental Challenges
- Product contamination incident during COVID-19 vaccine manufacturing resulting in a temporary suspension of manufacturing and FDA inspection.
Mitigation Strategies
- Initiated an investigation, implemented corrective actions, developed a comprehensive quality enhancement plan, and resumed manufacturing after working with the FDA and J&J.
Supply Chain Management
Responsible Procurement
- Supplier quality management department oversees a process to ensure that the supplier and the goods and services they provide meet pre-established standards that ensure the safety, quality, and efficacy of our products.
- Supply or service agreements include code of conduct expectations for the supplier, workers’ rights and safety, confidentiality, and applicable Federal Acquisition Regulations (FAR).
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: SASB, TCFD, UNSDGs
UN Sustainable Development Goals
- Goal 3
- Goal 8
- Goal 9
- Goal 10
- Goal 17
Contributions to SDGs outlined in Appendix
Reporting Period: 2021
Environmental Metrics
Total Energy Consumption:4,139,130 kWh/year (Canton facility)
ESG Focus Areas
- Access to Medicine
- Governmental Relationships
- Community Engagement
- Innovation
- Compliance
- Manufacturing and Product Quality
- Corporate Governance
- Patient and Drug Safety
- Diversity, Equity, and Inclusion
- Scientific Integrity
- Employee Engagement
- Supply Chain Management
- Environmental, Health, and Employee Safety
Environmental Achievements
- Partnered with Constellation to source Emission Free Energy Credits (EFECs) at Canton, Massachusetts facility, avoiding an estimated 29,333 metric tons of CO2e.
Social Achievements
- Launched three employee resource groups (Emerging Women, BRAVE, and BOLD).
- Supplied more than 10 million doses of NARCAN® Nasal Spray.
- Launched the Reverse the Silence campaign to address the opioid crisis.
- 61 percent of director-level and above roles filled by female or person of color candidates.
- 660 new colleagues onboarded through the global ARRIVE Program.
Governance Achievements
- Established a special committee on manufacturing and quality oversight.
- Expanded board of directors membership with a new independent director with extensive experience in healthcare compliance.
- Created and hired a new senior vice president to lead business compliance.
Climate Goals & Targets
Environmental Challenges
- FDA inspection of Camden facility resulted in a warning letter and reduced operational capacity.
Mitigation Strategies
- Implemented a Corrective and Preventive Action (CAPA) plan and a detailed site enhancement plan.
- Hired a CGMP consultant to provide oversight for production.
- Developed a comprehensive Compliance Action Plan (CAP).
Supply Chain Management
Responsible Procurement
- Developed a procurement policy aligned with ESG priorities.
- Supplier diversity program partnering with diverse suppliers.
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: TCFD, SASB
UN Sustainable Development Goals
- Goal 3
- Goal 8
- Goal 9
- Goal 10
- Goal 17
Reporting Period: 2022
Environmental Metrics
Total Carbon Emissions:40,434 tCO2e/year
Scope 1 Emissions:19,334 tCO2e/year
Scope 2 Emissions:21,099 tCO2e/year
Total Energy Consumption:69,237 MWh/year
Water Consumption:518,461 m3/year
Carbon Intensity:13.6 tCO2e/employee (2022)
ESG Focus Areas
- Access to Medicine
- Governmental Relationships
- Community Engagement
- Innovation
- Compliance
- Manufacturing and Product Quality
- Corporate Governance
- Patient and Drug Safety
- Diversity, Equity, and Inclusion
- Scientific Integrity
- Employee Engagement
- Supply Chain Management
- Environmental, Health, and Employee Safety
Environmental Achievements
- Collected data on Scope 1 and Scope 2 greenhouse gas (GHG) emissions.
Social Achievements
- Launched three employee resource groups (ERGs) to support women, veterans, and Black/African American colleagues.
- Delivered 63 instructor-led workshops to 1,100 employees.
- Donated 13,357 units (26,714 doses) of NARCAN® Nasal Spray.
- Donated 200 vials of BAT® to Ukraine.
Governance Achievements
- Appointed a new independent director, Sujata Dayal, to the board of directors.
- Established a special committee on manufacturing and quality oversight.
- Created a new senior vice president position to lead the business compliance function.
Climate Goals & Targets
Environmental Challenges
- U.S. Food and Drug Administration (FDA) issued a warning letter regarding the Camden facility.
Mitigation Strategies
- Took immediate action to make necessary remediations and improvements at the Camden facility.
- Provided updates to the FDA.
Supply Chain Management
Responsible Procurement
- Supplier Quality Management department ensures suppliers meet pre-established standards.
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: TCFD, SASB
UN Sustainable Development Goals
- Goal 3
- Goal 8
- Goal 9
- Goal 10
- Goal 17
Reporting Period: 2023
Environmental Metrics
Total Carbon Emissions:35,292 tCO2e/year
Scope 1 Emissions:16,856 tCO2e/year
Scope 2 Emissions:18,436 tCO2e/year
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:59,277 MWh/year
Water Consumption:481,358 m3/year
Waste Generated:Not disclosed
Carbon Intensity:13.9 tCO2e/FTE
ESG Focus Areas
- Talent Attraction, Engagement, and Development
- Ethics and Compliance
- Product Quality and Patient Safety
- Sustainable Innovation
- Product Affordability and Accessibility
- Responsible Supply Chain
- Clinical Trial Practices
- Supplier Product Quality, Reliability, and Compliance
- Diversity, Equity, and Inclusion
- ESG Oversight
- Climate Impact
- Occupational Health and Safety
Environmental Achievements
- Reduced Scope 1 and 2 emissions by 473 tCO2e at the Lansing, Michigan site through energy conservation measures.
Social Achievements
- Launched the Ready to Rescue campaign to combat the opioid epidemic, distributing ~5,000 Ready to Rescue kits.
- Donated 12,396 units (24,792 doses) of NARCAN® Nasal Spray in the U.S.
- Improved Culture of Quality Index Score by nearly three points over 11 months.
Governance Achievements
- Received FDA warning letter close-out letter for Camden facility, indicating adequate address of violations.
- Launched the “I Speak Up” campaign to improve quality and compliance culture.
- Revamped Code of Conduct and Business Ethics Policy with employee input.
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Not disclosed
Short-term Goals:
- Not disclosed
Environmental Challenges
- Developing a comprehensive understanding of Scope 3 emissions.
- Maintaining a strong cybersecurity posture.
- Navigating change and disruption within the company.
Mitigation Strategies
- Continuously refining methods to determine Scope 1 and 2 emissions and expanding data collection efforts for Scope 3.
- Implementing a certified information security program compliant with NIST framework and regulatory requirements.
- Prioritizing building skills needed to lead, adapt, and thrive during times of change through various programs.
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Supplier evaluations based on price, sustainability, financial stability, and government 'do not use' lists.
- Additional evaluations for GxP compliant suppliers.
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: TCFD, SASB
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Goal 3
- Goal 8
- Goal 9
- Goal 10
- Goal 17
Initiatives contribute to these goals through various programs and activities detailed in the report.
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed